Digital health case studyPharmaceutical
Pinpointing Oncology Ventures with Clinical Trial Capability in Emerging Markets
Client context: Large global pharmaceutical
Strategic question
Which oncology ventures in emerging markets can offer advice, patient cohorts or clinical trial capability at scale?
Decision enabled
What the client could do next
Enabled the clinical and BD teams to engage a short, highly qualified list of oncology ventures for further evaluation.
Approach
Combining HealthTech Alpha with structured ecosystem mapping, we evaluated 113 oncology-focused ventures across eight markets and built a highly prioritised target list aligned to clinical trial and cohort criteria.
Methodology
Strategic interpretation
Reframed emerging markets as credible clinical execution partners rather than peripheral geographies, and surfaced the specific ventures with partnership potential.
